Company intelligence / Profile preview

Ceres Biotech

Atlanta, Georgia, United States

Ownership: Private
Development stage: Other

Overview

Ceres Biotech is a specialized biotechnology company focused on the development of innovative therapeutic solutions derived from cannabinoid science. The company leverages advanced extraction and formulation technologies to create high-purity compounds targeting the endocannabinoid system for various medical applications. Their primary research efforts are directed toward addressing unmet needs in pain management, inflammatory conditions, and neurological health. By combining pharmaceutical-grade manufacturing with rigorous scientific validation, Ceres Biotech aims to bridge the gap between traditional botanical medicine and modern clinical therapeutics.

Therapeutic areas: ImmunologyNeurology
Modalities: Small moleculePeptides
Industry: Biotech

Beyond the preview

Go deeper on Ceres Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ceres Biotech.

Explore the full profile